| Literature DB >> 31792941 |
S M Green1, P L Leroy2, M G Roback3, M G Irwin4, G Andolfatto5, F E Babl6, E Barbi7, L R Costa8, A Absalom9, D W Carlson10, B S Krauss11, J Roelofse12, V M Yuen13, E Alcaino14, P S Costa15, K P Mason16.
Abstract
The multidisciplinary International Committee for the Advancement of Procedural Sedation presents the first fasting and aspiration prevention recommendations specific to procedural sedation, based on an extensive review of the literature. These were developed using Delphi methodology and assessment of the robustness of the available evidence. The literature evidence is clear that fasting, as currently practiced, often substantially exceeds recommended time thresholds and has known adverse consequences, for example, irritability, dehydration and hypoglycaemia. Fasting does not guarantee an empty stomach, and there is no observed association between aspiration and compliance with common fasting guidelines. The probability of clinically important aspiration during procedural sedation is negligible. In the post-1984 literature there are no published reports of aspiration-associated mortality in children, no reports of death in healthy adults (ASA physical status 1 or 2) and just nine reported deaths in adults of ASA physical status 3 or above. Current concerns about aspiration are out of proportion to the actual risk. Given the lower observed frequency of aspiration and mortality than during general anaesthesia, and the theoretical basis for assuming a lesser risk, fasting strategies in procedural sedation can reasonably be less restrictive. We present a consensus-derived algorithm in which each patient is first risk-stratified during their pre-sedation assessment, using evidence-based factors relating to patient characteristics, comorbidities, the nature of the procedure and the nature of the anticipated sedation technique. Graded fasting precautions for liquids and solids are then recommended for elective procedures based upon this categorisation of negligible, mild or moderate aspiration risk. This consensus statement can serve as a resource to practitioners and policymakers who perform and oversee procedural sedation in patients of all ages, worldwide.Entities:
Keywords: NPO guidelines; fasting; procedural sedation; pulmonary aspiration
Mesh:
Year: 2019 PMID: 31792941 PMCID: PMC7064977 DOI: 10.1111/anae.14892
Source DB: PubMed Journal: Anaesthesia ISSN: 0003-2409 Impact factor: 6.955
Figure 1Algorithm linking risk stratification and fasting guidance. Notes: (1) Suggested definitions for moderate obesity are a body mass index (BMI) of 30–39 kg.m−2 in adults or from the 85th up to the 95th BMI percentile based on age/sex in a child, and for severe obesity a BMI of 40 kg.m−2 or higher in an adult or at the 95th percentile or greater in a child. (2) Includes micrognathia, macroglossia and laryngomalacia; (3) Includes gastroparesis, achalasia, atresia, stricture and tracheoesophageal fistula; (4) Includes ileus, pseudo‐obstruction, pyloric stenosis and intussusception. (5) Clear liquids are generally considered to include water, fruit juices without pulp, clear tea, black coffee and specially prepared carbohydrate‐containing fluids. (6) Fasting intervals are not absolute, with exceptions permissible when the volumes of oral intake are minor, or the fasting time reasonably close.
Literature estimates of aspiration risk during procedural sedationa
| Study | Population | Principal Agent | Endoscopy? | Total Subjects | Aspiration overall | Aspiration during non‐fasted procedures | Aspiration mortality |
|---|---|---|---|---|---|---|---|
| Bhatt | Children | Ketamine | No | 6295 | None | None | None |
| Beach | Children | Propofol | Some | 139,142 | 1:13,914 | 1:12,701 | None |
| Chiaretti | Children | Propofol | Some | 36,516 | None | None | None |
| Friedrich | Adults | Propofol | All | 15,690 | 1:541 | Not stated | None |
| Rajasekaran | Children | Propofol | All | 12,447 | None | None | None |
| Agostoni | Mixed | Propofol | All | 17,999 | 1:1,000 | Not stated | None |
| Dean | Mostly adults | Propofol | None | 62,125 | None | Not stated | None |
| Green | Children | Ketamine | None | 8282 | None | None | None |
| Rex | Adults | Propofol | All | 646,080 | Not stated | Not stated | None |
| Horiuchi | Adults | Propofol | All | 10,662 | None | None | None |
| Vespasiano | Children | Propofol | None | 7304 | 1:7,304 | Not stated | None |
| Onody | Mostly Children | Nitrous oxide | Some | 35,828 | None | None | None |
| Tohda | Adults | Propofol | All | 27,500 | 1:6,875 | Not stated | None |
| Sanborn | Children | Pentobarbital | None | 16,467 | 1:8,234 | None stated | None |
| Walker | Adults | Propofol | All | 9152 | 1:9,152 | Not stated | None |
| Gall | Children | Nitrous oxide | Some | 7511 | None | None | None |
To include just the largest studies, we display those with 5000 or more patients. We also exclude studies which report duplicate subsets of patients.
Risk factors for pulmonary aspiration associated with procedural sedation
| Risk factor repeatedly reported without conflicting data (Quality of evidence: High): |
| Oesophageal endoscopy in adults |
| Risk factors reported more than once and not specifically refuted elsewhere (Quality of evidence – Moderate) |
| Greater comorbidities in children |
| Propofol as the sedative choice |
| Risk factors reported in a single study and not specifically corroborated or refuted elsewhere (Quality of evidence – Moderate) |
| Infant 12 months of age or less |
| Obstructive sleep apnoea in children |
| Oesophageal endoscopy in children |
| Bronchoscopy in children |
| Clinical features found to not be risk factors, with no conflicting data (Quality of evidence – Moderate) |
| Emergency procedure in children |
| Absence of fasting in children |
| Upper respiratory infection in children |
| Pregnancy in teenagers and adults |